Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Discovery & Translation

An in vivo CAR T manufacturing implant; plus Seer, Kither and more

BioCentury’s roundup of translational news

April 1, 2022 8:43 PM UTC

North Carolina State University and University of North Carolina at Chapel Hill scientists described in Nature Biotechnology an implantable scaffold, dubbed MASTER (Multifunctional Alginate Scaffold for T Cell Engineering and Release), that generated and released functional CAR T cells and controlled distal tumor growth in a xenograft mouse model of lymphoma.

When seeded with human peripheral blood mononuclear cells and viral vectors encoding a CD19-targeting CAR, the scaffold, which is subcutaneously implanted, provided an interface for gene transfer and mediated release of resulting CAR T cells. The authors wrote that MASTER “streamlines in vivo CAR-T cell manufacturing and reduces processing time to a single day.” ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article